BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 32812775)

  • 1. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal-jejunal bypass surgery suppresses hepatic de novo lipogenesis and alleviates liver fat accumulation in a diabetic rat model.
    Han H; Hu C; Wang L; Zhang G; Liu S; Li F; Sun D; Hu S
    Obes Surg; 2014 Dec; 24(12):2152-60. PubMed ID: 24898720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal jejunal bypass attenuates non-alcoholic fatty liver disease in western diet-obese rats.
    Ebertz CE; Bonfleur ML; Bertasso IM; Mendes MC; Lubaczeuski C; Araujo AC; Paes AM; de Amorim EM; Balbo SL
    Acta Cir Bras; 2014 Sep; 29(9):609-14. PubMed ID: 25252208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic
    Bertasso IM; Pietrobon CB; Ribeiro RA; Soares GM; Oliveira JC; Alegre-Maller ACP; Boschero AC; Araújo ACF; Guimarães ATB; Bonfleur ML; Balbo SL
    J Dev Orig Health Dis; 2022 Apr; 13(2):263-273. PubMed ID: 33998431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenal-jejunal bypass maintains hepatic S-adenosylmethionine/S-homocysteine ratio in diet-induced obese rats.
    Kim M; Rho Y; Park R; Jung J; Hwang GS; Seo YK; Seo JH; Heo Y; Ha TK; Ha E
    Surg Obes Relat Dis; 2021 Jul; 17(7):1359-1368. PubMed ID: 33753007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats.
    Cantelli KR; Soares GM; Ribeiro RA; Balbo SL; Lubaczeuski C; Boschero AC; Araújo AC; Bonfleur ML
    Braz J Med Biol Res; 2017 Mar; 50(5):e5858. PubMed ID: 28380195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal-jejunal bypass surgery up-regulates the expression of the hepatic insulin signaling proteins and the key regulatory enzymes of intestinal gluconeogenesis in diabetic Goto-Kakizaki rats.
    Sun D; Wang K; Yan Z; Zhang G; Liu S; Liu F; Hu C; Hu S
    Obes Surg; 2013 Nov; 23(11):1734-42. PubMed ID: 23700236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats.
    Han HF; Liu SZ; Zhang X; Wei M; Huang X; Yu WB
    World J Gastroenterol; 2022 Aug; 28(31):4338-4350. PubMed ID: 36159018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress.
    Mosinski JD; Pagadala MR; Mulya A; Huang H; Dan O; Shimizu H; Batayyah E; Pai RK; Schauer PR; Brethauer SA; Kirwan JP
    Acta Physiol (Oxf); 2016 Jun; 217(2):141-51. PubMed ID: 26663034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver steatosis in hypothalamic obese rats improves after duodeno-jejunal bypass by reduction in de novo lipogenesis pathway.
    Soares GM; Cantelli KR; Balbo SL; Ribeiro RA; Alegre-Maller ACP; Barbosa-Sampaio HC; Boschero AC; Araújo ACF; Bonfleur ML
    Life Sci; 2017 Nov; 188():68-75. PubMed ID: 28866102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic benefits of gastric bypass surgery in the mouse: The role of fecal losses.
    Barataud A; Vily-Petit J; Goncalves D; Zitoun C; Duchampt A; Philippe E; Gautier-Stein A; Mithieux G
    Mol Metab; 2020 Jan; 31():14-23. PubMed ID: 31918916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device.
    Casella-Mariolo J; Castagneto-Gissey L; Angelini G; Zoli A; Marini P; Bornstein SR; Pournaras DJ; Rubino F; le Roux CW; Mingrone G; Casella G
    EBioMedicine; 2019 Aug; 46():452-462. PubMed ID: 31401193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Bile Acid Signals After Duodenal-Jejunal Bypass Improve Non-alcoholic Steatohepatitis (NASH) in a Rodent Model of Diet-Induced NASH.
    Tsuchiya T; Naitoh T; Nagao M; Tanaka N; Watanabe K; Imoto H; Miyachi T; Motoi F; Unno M
    Obes Surg; 2018 Jun; 28(6):1643-1652. PubMed ID: 29235014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice.
    Pereira RM; Rodrigues KCDC; Anaruma CP; Sant'Ana MR; de Campos TDP; Gaspar RS; Canciglieri RDS; de Melo DG; Mekary RA; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
    J Endocrinol; 2019 Apr; 241(1):59-70. PubMed ID: 30878016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass.
    Han H; Wang L; Du H; Jiang J; Hu C; Zhang G; Liu S; Zhang X; Liu T; Hu S
    Obes Surg; 2015 Oct; 25(10):1802-9. PubMed ID: 25726319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents.
    Kindel TL; Martins PJ; Yoder SM; Jandacek RJ; Seeley RJ; D'Alessio DA; Obici S; Tso P
    Obesity (Silver Spring); 2011 Feb; 19(2):380-7. PubMed ID: 21030948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal-jejunal bypass surgery enhances glucose tolerance and beta-cell function in Western diet obese rats.
    Araujo AC; Bonfleur ML; Balbo SL; Ribeiro RA; de Freitas AC
    Obes Surg; 2012 May; 22(5):819-26. PubMed ID: 22411572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.